(Q36673752)

15 August 2017

1 reference

title

Tacrine: a pharmacological review (English)

1 reference

15 August 2017

Tacrine: A pharmacological review (English)

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

6 November 2022

author name string

S. E. Freeman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714613

6 November 2022

R. M. Dawson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1714613

6 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1714613

6 November 2022

publication date

1 January 1991

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:030100829190002I?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

https://api.elsevier.com/content/article/PII:030100829190002I?httpAccept=text/plain

6 November 2022

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

6 November 2022

published in

Progress in Neurobiology

1 reference

15 August 2017

volume

36

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

257-277

1 reference

Tetrahydroaminoacridine inhibits human and rat brain monoamine oxidase

15 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Tetrahydroaminoacridine antagonism to narcotic addiction

6 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Tetrahydro-9-aminoacridine (THA) interacts with the phencyclidine (PCP) receptor site.

6 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Some possibilities of protection against acetylcholinesterase inhibition by organophosphates in vivo

6 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Tacrine inhibition of serum cholinesterase and prolonged succinylcholine action

6 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate

6 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Cholinergic blockade as an approach to the development of new psychotropic agents

6 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Identification of a family of muscarinic acetylcholine receptor genes

6 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

The striatum and cerebral cortex express different muscarinic receptor mRNAs

6 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Tetrahydroaminoacridine but not 4-aminopyridine inhibits high-affinity choline uptake in striatal and hippocampal synaptosomes

6 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Toxins in the characterization of potassium channels

6 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Inhibition of rat brain histamine-N-methyltransferase by 9-amino-1,2,3,4-tetrahydroacridine (THA).

6 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Tetrahydroaminoacridine selectively attenuates NMDA receptor-mediated neurotoxicity

6 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Selective loss of central cholinergic neurons in Alzheimer's disease

6 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Tacrine slows the rate of ageing of sarin-inhibited acetylcholinesterase

6 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Reversibility of the inhibition of acetylcholinesterase by tacrine

6 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Inhibitory effect of 1,2,3,4-tetrahydro-9-aminoacridine on the depolarization-induced release of GABA from cerebral cortex

6 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

The action of morphine and antagonists of the narcotic action of morphine on acetyl choline synthesis in brain.

6 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

The actions of tacrine and amiphenazole on acetylcholine metabolism in the guinea pig ileum

6 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat

6 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current

6 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease

6 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Effects of THA on ionic currents in myelinated axons of Xenopus laevis

6 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

A new and rapid colorimetric determination of acetylcholinesterase activity

6 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

The effect of some acridine compounds on the growth and respiration of E. coli

6 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Long-term oral administration of memory-enhancing doses of tacrine in mice: a study of potential toxicity and side effects

6 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Effect of acute arecoline, tacrine, and arecoline + tacrine post-training administration on retention in late middle-aged mice.

6 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Scopolamine effects on memory retention in mice: a model of dementia?

6 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Memory enhancement: supra-additive effect of subcutaneous cholinergic drug combinations in mice.

6 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine

6 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease

6 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Facilitatory drug action on the isolated phrenic nerve-diaphragm preparation of the rat

6 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Blockade of a cardiac K+ channel by tacrine: interactions with muscarinic and adenosine receptors

6 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Is the inhibitory effect of somatostatin on the heart due to K+ channel activation?

6 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Blocking Effect of Tetrahydroaminacrin on a New Psychotomimetic Agent

6 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Tetrahydroaminacrin as a decurarising agent

6 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Changes in cytosolic free calcium with 1,2,3,4-tetrahydro-5-aminoacridine, 4-aminopyridine and 3,4-diaminopyridine

6 November 2022

62

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

The protection of animals against organophosphate poisoning by pretreatment with a carbamate

6 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Relation of brain regional physostigmine concentration to cholinesterase activity and acetylcholine and choline levels in rat.

6 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain.

6 November 2022

65

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

9-Amino-1,2,3,4-tetrahydroacridine (THA) blocks agonist-induced potassium conductance in rat hippocampal neurones

6 November 2022

66

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine

6 November 2022

68

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Some aspects of the metabolism of morphine-N-oxide

6 November 2022

71

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Anticholinesterase activity of tetrahydroaminacrine and succinyl choline hydrolysis

6 November 2022

73

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Low dose tetrahydroaminoacridine (THA) improves cognitive function but does not affect brain acetylcholine in rats

6 November 2022

74

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Tetrahydroaminacrine in anaesthesia.

6 November 2022

78

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro

6 November 2022

80

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

EEG and Behavioral Aspects of the Interaction of Anticholinergic Hallucinogens with Centrally Active Compounds

6 November 2022

83

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

The action of tacrine on neuromuscular transmission: a comparison with hexafluorenium

6 November 2022

84

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Inhibitory effect of 9-amino-1,2,3,4-tetrahydroacridine (THA) on the potassium current of rabbit sinoatrial node.

6 November 2022

85

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Interactions between cholinergic and peptidergic systems in the cerebral cortex and hippocampus

6 November 2022

88

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

SOME ANTAGONISTS OF ATROPINE-LIKE PSYCHOTOMIMETICS

6 November 2022

89

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Somatostatin activates an inwardly rectifying K+ channel in neonatal rat atrial cells.

6 November 2022

90

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

EFFECT OF ANTICHOLINERGIC PSYCHOTOMIMETICS ON MOTOR ACTIVITY AND BODY TEMPERATURE

6 November 2022

91

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Effect of nicotine and tacrine on acetylcholine release from rat cerebral cortical slices

6 November 2022

92

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Antagonism by cholinergic drugs of behavioural effects in cats of an anticholinergic psychotomimetic drug and enhancement by nicotine

6 November 2022

93

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Suxamethonium "extension" by tetrahydroaminacrine

6 November 2022

95

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Quantitative whole-body autoradiographic determination of tacrine tissue distribution in rats following intravenous or oral dose

6 November 2022

96

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles

6 November 2022

98

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Is the effect of somatostatin on muscarinic receptors selective to M1 type?

6 November 2022

99

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Attenuation of serotonin-suppressed [3H]acetylcholine release by tetrahydroaminoacridine and dendrotoxin: interaction with minaprine binding site

6 November 2022

100

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Pharmacological and biochemical assessment of SM-10888, a novel cholinesterase inhibitor

6 November 2022

102

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Ditran and its antagonists in a mixed psychiatric population.

6 November 2022

103

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes

6 November 2022

105

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?

6 November 2022

106

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Tetrahydroaminoacridine induces opposite changes in muscarinic and nicotinic receptors in rat brain

6 November 2022

107

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

9-Amino-1,2,3,4-tetrahydroacridine (THA) is a potent blocker of cardiac potassium channels

6 November 2022

109

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Effects of tetrahydroaminoacridine on M1 and M2 muscarine receptors

6 November 2022

113

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro

6 November 2022

115

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Effects of LF-14, THA and physostigmine in rat hippocampus and cerebral cortex

6 November 2022

118

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Anticurare activity of tacrine (THA) in vitro

6 November 2022

120

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

THA increases action potential duration of central histamine neurons in vitro

6 November 2022

121

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prisms

6 November 2022

122

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons

6 November 2022

123

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Relative binding sites of pharmacologically active ligands on bovine erythrocyte acetylcholinesterase

6 November 2022

125

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

6 November 2022

Morphine Antagonism

129

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

The pharmacology of some new anti-cholinesterases

6 November 2022

130

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

6 November 2022

Morphine antagonism.

131

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

6 November 2022

Morphine Antagonists

132

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

6 November 2022

Morphine antagonism

133

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Cholinesterase inhibitor therapy for Alzheimer dementia: what do animal models tell us?

6 November 2022

135

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics

6 November 2022

136

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Hydrophobic binding site in acetylcholinesterase

6 November 2022

137

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Excitatory actions of tetrahydro-9-aminoacridine (THA) on hippocampal pyramidal neurons

6 November 2022

138

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Treatment of Intractable Pain with Morphine and Tetrahydroaminacrine

6 November 2022

139

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum

6 November 2022

140

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

THA--a review of the literature and its use in treatment of five overdose patients

6 November 2022

141

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

6 November 2022

142

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Tetrahydroaminoacridine (tacrine) stimulates neurosecretion at mammalian motor endplates

6 November 2022

147

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors

6 November 2022

148

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

A suitable method to monitor inhibition of cholinesterase activities in tissues as induced by reversible enzyme inhibitors

6 November 2022

149

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Pharmacological evidence that somatostatin activates the m-current in hippocampal pyramidal neurons.

6 November 2022

153

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

The role of the cholinergic system in the development of increased naloxone potency in mice

6 November 2022

154

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

A note on the effects of 2,4-diamino-5-phenylthiazole and 1, 2, 3, 4-tetrahydro-9-aminoacridine on morphine metabolism

6 November 2022

155

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Kinetics of 9-aminoacridine block of single Na channels

6 November 2022

158

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Dynamics of 9-aminoacridine block of sodium channels in squid axons

6 November 2022

159

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Interactions of aminopyridines with potassium channels of squid axon membranes

6 November 2022

160

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

Tetrahydroaminoacridine potentiates neurotoxicity of quinolinic acid in rat striatum

6 November 2022

162

1 reference

https://api.crossref.org/works/10.1016/0301-0082(91)90002-I

6 November 2022

Identifiers

1 reference

15 August 2017

1 reference